APO RESEARCH · REPORT
Remifentanil Hydrochloride
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Product & engineering
Understand the product.
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
Selected research
Industry Research
Remifentanil Hydrochloride Industry Research Report 2026
Market perspective
Remifentanil Hydrochloride (also named Ultiva) is a kind of white to off-white crystalline powder or crystals that used to maintain analgesia and anesthesia induction of general anesthesia. Remifentanil Hydrochloride is freely soluble in water, sparingly soluble in ethanol, slightly soluble in isopropyl alcohol and very slightly soluble in methyl isobutyl ketone.
Remifentanil Hydrochloride should be administered only in a setting fully equipped for the monitoring and support of respiratory and cardiovascular function and by persons specifically trained in the use of anaesthetic drugs and the recognition and management of the expected adverse effects of potent opioids, including respiratory and cardiac resuscitation. Such training must include the establishment and maintenance of a patent airway and assisted ventilation.
In Europe, Remifentanil Hydrochloride key players include GSK, Macfarlan Smith, Abbott, Mylan, Arevipharma, etc. The top five players hold a share about 85%.
Read the full market overview
UK is the largest market, with a share about 20%, followed by Germany and France, having a total share about 30 percent.
In terms of product, 1mg/Pcs is the largest segment, with a share about 85%. And in terms of application, the largest application is Endotracheal Intubation Operation, followed by Neurosurgery, Outpatient Surgery, Postoperative Analgesia, etc.
Report Scope
This report quantifies the global Remifentanil Hydrochloride market in terms of revenue (US$ million) and, where applicable, sales volume (K Pcs), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Pcs) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Remifentanil Hydrochloride Market by Company
GSK
Macfarlan Smith
Abbott
Mylan
Arevipharma
AMRI
Remifentanil Hydrochloride Segment by Type
1mg/Pcs
2mg/Pcs
5mg/Pcs
Remifentanil Hydrochloride Segment by Application
Endotracheal Intubation Operation
Neurosurgery
Outpatient Surgery
Postoperative Analgesia
Other
Remifentanil Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Remifentanil Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Remifentanil Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Remifentanil Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Remifentanil Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Remifentanil Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Remifentanil Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg/Pcs
- 2mg/Pcs
- 5mg/Pcs
Applications
- Endotracheal Intubation Operation
- Neurosurgery
- Outpatient Surgery
- Postoperative Analgesia
- Other
Companies covered
- GSK
- Macfarlan Smith
- Abbott
- Mylan
- Arevipharma
- AMRI
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Remifentanil Hydrochloride Market Size (2021-2032)
- 2.2.2 Global Remifentanil Hydrochloride Sales (2021-2032)
- 2.2.3 Global Remifentanil Hydrochloride Market Average Price (2021-2032)
- 2.3 Remifentanil Hydrochloride by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1mg/Pcs
- 2.3.3 2mg/Pcs
- 2.3.4 5mg/Pcs
- 2.4 Remifentanil Hydrochloride by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Endotracheal Intubation Operation
- 2.4.3 Neurosurgery
- 2.4.4 Outpatient Surgery
- 2.4.5 Postoperative Analgesia
- 2.4.6 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Remifentanil Hydrochloride Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Remifentanil Hydrochloride Sales (K Pcs) of Manufacturers (2021-2026)
- 3.3 Global Remifentanil Hydrochloride Revenue of Manufacturers (2021-2026)
- 3.4 Global Remifentanil Hydrochloride Average Price by Manufacturers (2021-2026)
- 3.5 Global Remifentanil Hydrochloride Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Remifentanil Hydrochloride, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Remifentanil Hydrochloride, Product Type & Application
- 3.8 Global Manufacturers of Remifentanil Hydrochloride, Established Date
- 3.9 Global Remifentanil Hydrochloride Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Remifentanil Hydrochloride Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Macfarlan Smith
- 4.2.1 Macfarlan Smith Company Information
- 4.2.2 Macfarlan Smith Business Overview
- 4.2.3 Macfarlan Smith Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Macfarlan Smith Remifentanil Hydrochloride Product Portfolio
- 4.2.5 Macfarlan Smith Recent Developments
- 4.3 Abbott
- 4.3.1 Abbott Company Information
- 4.3.2 Abbott Business Overview
- 4.3.3 Abbott Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Abbott Remifentanil Hydrochloride Product Portfolio
- 4.3.5 Abbott Recent Developments
- 4.4 Mylan
- 4.4.1 Mylan Company Information
- 4.4.2 Mylan Business Overview
- 4.4.3 Mylan Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mylan Remifentanil Hydrochloride Product Portfolio
- 4.4.5 Mylan Recent Developments
- 4.5 Arevipharma
- 4.5.1 Arevipharma Company Information
- 4.5.2 Arevipharma Business Overview
- 4.5.3 Arevipharma Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Arevipharma Remifentanil Hydrochloride Product Portfolio
- 4.5.5 Arevipharma Recent Developments
- 4.6 AMRI
- 4.6.1 AMRI Company Information
- 4.6.2 AMRI Business Overview
- 4.6.3 AMRI Remifentanil Hydrochloride Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AMRI Remifentanil Hydrochloride Product Portfolio
- 4.6.5 AMRI Recent Developments
5 Global Remifentanil Hydrochloride Market Scenario by Region
- 5.1 Global Remifentanil Hydrochloride Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Remifentanil Hydrochloride Sales by Region: 2021-2032
- 5.2.1 Global Remifentanil Hydrochloride Sales by Region: 2021-2026
- 5.2.2 Global Remifentanil Hydrochloride Sales by Region: 2027-2032
- 5.3 Global Remifentanil Hydrochloride Revenue by Region: 2021-2032
- 5.3.1 Global Remifentanil Hydrochloride Revenue by Region: 2021-2026
- 5.3.2 Global Remifentanil Hydrochloride Revenue by Region: 2027-2032
- 5.4 North America Remifentanil Hydrochloride Market Facts & Figures by Country
- 5.4.1 North America Remifentanil Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Remifentanil Hydrochloride Sales by Country (2021-2032)
- 5.4.3 North America Remifentanil Hydrochloride Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Remifentanil Hydrochloride Market Facts & Figures by Country
- 5.5.1 Europe Remifentanil Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Remifentanil Hydrochloride Sales by Country (2021-2032)
- 5.5.3 Europe Remifentanil Hydrochloride Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Remifentanil Hydrochloride Market Facts & Figures by Country
- 5.6.1 Asia Pacific Remifentanil Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Remifentanil Hydrochloride Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Remifentanil Hydrochloride Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Remifentanil Hydrochloride Market Facts & Figures by Country
- 5.7.1 South America Remifentanil Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Remifentanil Hydrochloride Sales by Country (2021-2032)
- 5.7.3 South America Remifentanil Hydrochloride Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Remifentanil Hydrochloride Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Remifentanil Hydrochloride Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Remifentanil Hydrochloride Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Remifentanil Hydrochloride Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Remifentanil Hydrochloride Sales by Type (2021-2032)
- 6.1.1 Global Remifentanil Hydrochloride Sales by Type (2021-2032) & (K Pcs)
- 6.1.2 Global Remifentanil Hydrochloride Sales Market Share by Type (2021-2032)
- 6.2 Global Remifentanil Hydrochloride Revenue by Type (2021-2032)
- 6.2.1 Global Remifentanil Hydrochloride Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Remifentanil Hydrochloride Revenue Market Share by Type (2021-2032)
- 6.3 Global Remifentanil Hydrochloride Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Remifentanil Hydrochloride Sales by Application (2021-2032)
- 7.1.1 Global Remifentanil Hydrochloride Sales by Application (2021-2032) & (K Pcs)
- 7.1.2 Global Remifentanil Hydrochloride Sales Market Share by Application (2021-2032)
- 7.2 Global Remifentanil Hydrochloride Revenue by Application (2021-2032)
- 7.2.1 Global Remifentanil Hydrochloride Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Remifentanil Hydrochloride Revenue Market Share by Application (2021-2032)
- 7.3 Global Remifentanil Hydrochloride Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Remifentanil Hydrochloride Value Chain Analysis
- 8.1.1 Remifentanil Hydrochloride Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Remifentanil Hydrochloride Production Mode & Process
- 8.2 Remifentanil Hydrochloride Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Remifentanil Hydrochloride Distributors
- 8.2.3 Remifentanil Hydrochloride Customers
9 Global Remifentanil Hydrochloride Analyzing Market Dynamics
- 9.1 Remifentanil Hydrochloride Industry Trends
- 9.2 Remifentanil Hydrochloride Industry Drivers
- 9.3 Remifentanil Hydrochloride Industry Opportunities and Challenges
- 9.4 Remifentanil Hydrochloride Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst